About the Equity, Diversity & Inclusivity (EDI) Strategic Advisory Working Group
The OMERACT Equity, Diversity, and Inclusion (EDI) Strategic Advisory Working Group serves a dual purpose within OMERACT. This hybrid group operates as a traditional working group focused on EDI initiatives and projects and is a strategic advisory body to the OMERACT Management Group. This distinctive structure enables the group to implement actionable EDI efforts and provide expert guidance to inform OMERACT's overarching policies and practices.
Through our dual role, we are committed to:
-
Ensuring Diverse Participation
-
Fostering Cultural Openness
-
Supporting Inclusive Working Groups
-
Expanding Global Collaborator Engagement
-
Improving Accessibility and Inclusivity
Jennifer Barton
Co-Chair
Francis Guillemin
Co-Chair
Grayson Schultz
Co-Chair & Patient Research Partner
Grace Wright
Co-Chair
Maya Desai
Patient Research Partner
Kamini Kuchinad
Fellow
Megan Thomas
Fellow
Embracing Unity: Advancing Equity, Diversity, and Inclusion - OMERACT 2023 Session
RECENT WORKING GROUP PUBLICATIONS
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity.
Validation Studies of Rheumatoid Arthritis Patient-Reported Outcome Measures in Populations at Risk for Inequity: A Systematic Review and Analysis Using the OMERACT Summary of Measurement Properties Equity Table
Development of an extension of the OMERACT Summary of Measurement Properties table to capture equity considerations: SOMP-Equity
Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group
Towards ensuring health equity: Readability and cultural equivalence of OMERACT patient-reported outcome measures
Including Health Equity Considerations in Development of Instruments for Rheumatology Research: An Introduction to a Novel OMERACT Paradigm